Published in J Mol Biol on December 05, 1997
Automated selection of positions determining functional specificity of proteins by comparative analysis of orthologous groups in protein families. Protein Sci (2004) 1.91
Predicting specificity-determining residues in two large eukaryotic transcription factor families. Nucleic Acids Res (2005) 1.30
Essential helix interactions in the anion transporter domain of prestin revealed by evolutionary trace analysis. J Neurosci (2006) 1.22
ConSurf 2016: an improved methodology to estimate and visualize evolutionary conservation in macromolecules. Nucleic Acids Res (2016) 1.18
SiteLight: binding-site prediction using phage display libraries. Protein Sci (2003) 1.17
A regulator of G protein signaling interaction surface linked to effector specificity. Proc Natl Acad Sci U S A (2000) 1.15
Side-chain conformational entropy at protein-protein interfaces. Protein Sci (2002) 1.14
Activation of androgen receptor function by a novel nuclear protein kinase. Mol Biol Cell (1998) 1.13
Computational methods in drug design: modeling G protein-coupled receptor monomers, dimers, and oligomers. AAPS J (2006) 1.09
A formal perturbation equation between genotype and phenotype determines the Evolutionary Action of protein-coding variations on fitness. Genome Res (2014) 1.08
Recurrent use of evolutionary importance for functional annotation of proteins based on local structural similarity. Protein Sci (2006) 1.08
Separation of recombination and SOS response in Escherichia coli RecA suggests LexA interaction sites. PLoS Genet (2011) 1.07
Role for the regulator of G-protein signaling homology domain of G protein-coupled receptor kinases 5 and 6 in beta 2-adrenergic receptor and rhodopsin phosphorylation. Mol Pharmacol (2009) 1.05
Molecular defects in human carbamoy phosphate synthetase I: mutational spectrum, diagnostic and protein structure considerations. Hum Mutat (2011) 1.04
Evolution: a guide to perturb protein function and networks. Curr Opin Struct Biol (2010) 0.97
Evolutionary trace for prediction and redesign of protein functional sites. Methods Mol Biol (2012) 0.94
SDR: a database of predicted specificity-determining residues in proteins. Nucleic Acids Res (2008) 0.92
Identification of similar regions of protein structures using integrated sequence and structure analysis tools. BMC Struct Biol (2006) 0.92
Total sequence decomposition distinguishes functional modules, "molegos" in apurinic/apyrimidinic endonucleases. BMC Bioinformatics (2002) 0.89
The evolutionary origins and catalytic importance of conserved electrostatic networks within TIM-barrel proteins. Protein Sci (2005) 0.89
Solution structure of inhibitor-free human metalloelastase (MMP-12) indicates an internal conformational adjustment. J Mol Biol (2007) 0.89
Prediction and experimental validation of enzyme substrate specificity in protein structures. Proc Natl Acad Sci U S A (2013) 0.87
Computing highly correlated positions using mutual information and graph theory for G protein-coupled receptors. PLoS One (2009) 0.87
Combination of multiple alignment analysis and surface mapping paves a way for a detailed pathway reconstruction--the case of VHL (von Hippel-Lindau) protein and angiogenesis regulatory pathway. Protein Sci (2004) 0.86
Identification of functionally important residues/domains in membrane proteins using an evolutionary approach coupled with systematic mutational analysis. Methods Mol Biol (2009) 0.80
Reverse conservation analysis reveals the specificity determining residues of cytochrome P450 family 2 (CYP 2). Evol Bioinform Online (2008) 0.80
Electrostatic and functional analysis of the seven-bladed WD beta-propellers. Evol Bioinform Online (2008) 0.79
Feature amplified voting algorithm for functional analysis of protein superfamily. BMC Genomics (2010) 0.78
Cube-DB: detection of functional divergence in human protein families. Nucleic Acids Res (2011) 0.77
Cube - an online tool for comparison and contrasting of protein sequences. PLoS One (2013) 0.75
Predicting phenotype from genotype: Improving accuracy through more robust experimental and computational modeling. Hum Mutat (2017) 0.75
Rapid bacteriophage sedimentation in the presence of polyethylene glycol and its application to large-scale virus purification. Virology (1970) 21.42
Two distinct transcription factors bind to the HSV thymidine kinase promoter in vitro. Cell (1985) 11.03
Steroid receptor regulated transcription of specific genes and gene networks. Annu Rev Genet (1985) 10.62
Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. Proc Natl Acad Sci U S A (1993) 10.36
An evolutionary trace method defines binding surfaces common to protein families. J Mol Biol (1996) 9.31
Eight prion strains have PrP(Sc) molecules with different conformations. Nat Med (1998) 9.01
Bayesian statistical analysis of protein side-chain rotamer preferences. Protein Sci (1997) 7.92
Crystallographic analysis of the interaction of the glucocorticoid receptor with DNA. Nature (1991) 7.46
DNA sequences bound specifically by glucocorticoid receptor in vitro render a heterologous promoter hormone responsive in vivo. Cell (1983) 7.39
Transcription factor interactions: selectors of positive or negative regulation from a single DNA element. Science (1990) 6.72
Sequence-specific binding of glucocorticoid receptor to MTV DNA at sites within and upstream of the transcribed region. Cell (1983) 6.01
Two signals mediate hormone-dependent nuclear localization of the glucocorticoid receptor. EMBO J (1987) 5.76
Structure and specificity of nuclear receptor-coactivator interactions. Genes Dev (1998) 5.28
Reduced levels of hsp90 compromise steroid receptor action in vivo. Nature (1990) 5.23
Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein. Cell (1995) 5.16
Prediction of protein side-chain rotamers from a backbone-dependent rotamer library: a new homology modeling tool. J Mol Biol (1997) 4.79
Genetic complementation of a glucocorticoid receptor deficiency by expression of cloned receptor cDNA. Cell (1986) 4.66
Chimaeras of myc oncoprotein and steroid receptors cause hormone-dependent transformation of cells. Nature (1989) 4.65
Reversible and persistent changes in chromatin structure accompany activation of a glucocorticoid-dependent enhancer element. Cell (1984) 4.42
Prion protein biology. Cell (1998) 4.20
A movable and regulable inactivation function within the steroid binding domain of the glucocorticoid receptor. Cell (1988) 4.15
Improvements in protein secondary structure prediction by an enhanced neural network. J Mol Biol (1990) 4.10
Structure of the recombinant full-length hamster prion protein PrP(29-231): the N terminus is highly flexible. Proc Natl Acad Sci U S A (1997) 4.10
Steroid receptors: elements for modulation of eukaryotic transcription. Annu Rev Biochem (1976) 4.08
Roles of SWI1, SWI2, and SWI3 proteins for transcriptional enhancement by steroid receptors. Science (1992) 4.06
Allosteric effects of DNA on transcriptional regulators. Nature (1998) 3.94
Evidence for protein X binding to a discontinuous epitope on the cellular prion protein during scrapie prion propagation. Proc Natl Acad Sci U S A (1997) 3.78
The glucocorticoid receptor inhibits NFkappaB by interfering with serine-2 phosphorylation of the RNA polymerase II carboxy-terminal domain. Genes Dev (2000) 3.71
Mapping of linear and circular forms of mouse mammary tumor virus DNA with restriction endonucleases: evidence for a large specific deletion occurring at high frequency during circularization. Proc Natl Acad Sci U S A (1978) 3.45
Dexamethasone-mediated induction of mouse mammary tumor virus RNA: a system for studying glucocorticoid action. Cell (1975) 3.44
Solution structure of a 142-residue recombinant prion protein corresponding to the infectious fragment of the scrapie isoform. Proc Natl Acad Sci U S A (1997) 3.42
Glucocorticoid receptor mutants that are constitutive activators of transcriptional enhancement. Nature (1987) 3.42
The function and structure of the metal coordination sites within the glucocorticoid receptor DNA binding domain. Nature (1988) 3.41
Acridine and phenothiazine derivatives as pharmacotherapeutics for prion disease. Proc Natl Acad Sci U S A (2001) 3.39
Glucocorticoid-stimulated accumulation of mouse mammary tumor virus RNA: increased rate of synthesis of viral RNA. Proc Natl Acad Sci U S A (1977) 3.31
Co-evolution of proteins with their interaction partners. J Mol Biol (2000) 3.23
Mammalian glucocorticoid receptor derivatives enhance transcription in yeast. Science (1988) 3.16
A conformational transition at the N terminus of the prion protein features in formation of the scrapie isoform. J Mol Biol (1997) 2.95
Ataxia in prion protein (PrP)-deficient mice is associated with upregulation of the novel PrP-like protein doppel. J Mol Biol (1999) 2.92
Vectors for constitutive and inducible gene expression in yeast. Methods Enzymol (1991) 2.88
Mineralocorticoid and glucocorticoid receptor activities distinguished by nonreceptor factors at a composite response element. Science (1993) 2.77
Early events in the stimulation of mammary tumor virus RNA synthesis by glucocorticoids. Novel assays of transcription rates. J Biol Chem (1984) 2.68
Solution structure of the glucocorticoid receptor DNA-binding domain. Science (1990) 2.64
Purified glucocorticoid receptors bind selectively in vitro to a cloned DNA fragment whose transcription is regulated by glucocorticoids in vivo. Proc Natl Acad Sci U S A (1981) 2.63
Strain-specified relative conformational stability of the scrapie prion protein. Protein Sci (2001) 2.60
Signal transduction and transcriptional regulation by glucocorticoid receptor-LexA fusion proteins. Science (1988) 2.52
Hormone-mediated repression: a negative glucocorticoid response element from the bovine prolactin gene. Genes Dev (1988) 2.47
Functional dissection of the hormone and DNA binding activities of the glucocorticoid receptor. EMBO J (1987) 2.46
Copper binding to the prion protein: structural implications of four identical cooperative binding sites. Proc Natl Acad Sci U S A (1999) 2.44
Prion protein gene variation among primates. J Mol Biol (1995) 2.43
Chromosomal position effects determine transcriptional potential of integrated mammary tumor virus DNA. J Mol Biol (1982) 2.38
Collecting and harvesting biological data: the GPCRDB and NucleaRDB information systems. Nucleic Acids Res (2001) 2.37
Glucocorticoid receptor mutants that define a small region sufficient for enhancer activation. Science (1987) 2.33
Prion protein selectively binds copper(II) ions. Biochemistry (1998) 2.32
Dexamethasone regulation of alpha 1-acid glycoprotein and other acute phase reactants in rat liver and hepatoma cells. J Biol Chem (1983) 2.26
Mutations in the glucocorticoid receptor zinc finger region that distinguish interdigitated DNA binding and transcriptional enhancement activities. Genes Dev (1989) 2.15
Recombinant scrapie-like prion protein of 106 amino acids is soluble. Proc Natl Acad Sci U S A (1996) 2.12
Mouse mammary tumor virus DNA in infected rat cells: characterization of unintegrated forms. Cell (1977) 2.11
Integration and transcription of mouse mammary tumor virus DNA in rat hepatoma cells. Proc Natl Acad Sci U S A (1979) 2.08
Isolation of Hsp90 mutants by screening for decreased steroid receptor function. Proc Natl Acad Sci U S A (1993) 2.07
Identification of the Cu2+ binding sites in the N-terminal domain of the prion protein by EPR and CD spectroscopy. Biochemistry (2000) 2.02
Exploiting the basis of proline recognition by SH3 and WW domains: design of N-substituted inhibitors. Science (1998) 2.01
Infection of cultured rat hepatoma cells by mouse mammary tumor virus. Cell (1977) 1.98
Factor recruitment and TIF2/GRIP1 corepressor activity at a collagenase-3 response element that mediates regulation by phorbol esters and hormones. EMBO J (2001) 1.91
COOH-terminal sequence of the cellular prion protein directs subcellular trafficking and controls conversion into the scrapie isoform. Proc Natl Acad Sci U S A (1997) 1.89
Mitogen-activated and cyclin-dependent protein kinases selectively and differentially modulate transcriptional enhancement by the glucocorticoid receptor. Mol Cell Biol (1997) 1.88
High-level expression and characterization of a purified 142-residue polypeptide of the prion protein. Biochemistry (1996) 1.87
Prion protein of 106 residues creates an artifical transmission barrier for prion replication in transgenic mice. Cell (1999) 1.87
Identification of a prion protein epitope modulating transmission of bovine spongiform encephalopathy prions to transgenic mice. Proc Natl Acad Sci U S A (1997) 1.87
Two different factors act separately or together to specify functionally distinct activities at a single transcriptional enhancer. Mol Cell Biol (1986) 1.86
Solution structure of Syrian hamster prion protein rPrP(90-231). Biochemistry (1999) 1.86
Three amino acid substitutions selectively disrupt the activation but not the repression function of the glucocorticoid receptor N terminus. J Biol Chem (1997) 1.85
Regulatory crosstalk at composite response elements. Trends Biochem Sci (1991) 1.85
The immunoglobulin octanucleotide: independent activity and selective interaction with enhancers. Science (1987) 1.84
Folding of prion protein to its native alpha-helical conformation is under kinetic control. J Biol Chem (2001) 1.84
Four helix bundle diversity in globular proteins. J Mol Biol (1994) 1.84
Heritable disorder resembling neuronal storage disease in mice expressing prion protein with deletion of an alpha-helix. Nat Med (1997) 1.83
Selective neuronal targeting in prion disease. Neuron (1997) 1.82
Structure-based inhibitor design by using protein models for the development of antiparasitic agents. Proc Natl Acad Sci U S A (1993) 1.82
Characterization of a steroid hormone receptor gene and mRNA in wild-type and mutant cells. Nature (1985) 1.80
Hold 'em and fold 'em: chaperones and signal transduction. Science (1995) 1.74
Elimination of prions by branched polyamines and implications for therapeutics. Proc Natl Acad Sci U S A (1999) 1.73
Intracellular receptor concentration limits glucocorticoid-dependent enhancer activity. Mol Endocrinol (1987) 1.73
Protein folding: evaluation of some simple rules for the assembly of helices into tertiary structures with myoglobin as an example. J Mol Biol (1979) 1.72
Sequence-specific polypeptoids: a diverse family of heteropolymers with stable secondary structure. Proc Natl Acad Sci U S A (1998) 1.70
Mutational and secondary structural analysis of the basolateral sorting signal of the polymeric immunoglobulin receptor. J Cell Biol (1993) 1.68
Turn prediction in proteins using a pattern-matching approach. Biochemistry (1986) 1.65
A synthetic peptide initiates Gerstmann-Sträussler-Scheinker (GSS) disease in transgenic mice. J Mol Biol (2000) 1.65
A combinatorial approach to the discovery of efficient cationic peptoid reagents for gene delivery. Proc Natl Acad Sci U S A (1998) 1.65
Prion protein peptides induce alpha-helix to beta-sheet conformational transitions. Biochemistry (1995) 1.64
Genetic dissection of the signaling domain of a mammalian steroid receptor in yeast. Mol Biol Cell (1992) 1.64
Binding of neural cell adhesion molecules (N-CAMs) to the cellular prion protein. J Mol Biol (2001) 1.63
Identification of two prion protein regions that modify scrapie incubation time. J Virol (2001) 1.63
Mammary tumor virus DNA contains sequences required for its hormone-regulated transcription. Cell (1981) 1.61
Genetic approaches to steroid hormone action. Recent Prog Horm Res (1976) 1.59
Hydrogen bonds involving sulfur atoms in proteins. Proteins (1991) 1.58
Copper binding to octarepeat peptides of the prion protein monitored by mass spectrometry. Protein Sci (2000) 1.57
Conformational transitions in peptides containing two putative alpha-helices of the prion protein. J Mol Biol (1995) 1.57
In vitro antimalarial activity of chalcones and their derivatives. J Med Chem (1995) 1.56
The p23 molecular chaperones act at a late step in intracellular receptor action to differentially affect ligand efficacies. Genes Dev (2000) 1.54